256 results
Page 3 of 13
F-1
qh7xkl23ymutlp27
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-99.1
lob3bc 9om
27 Feb 24
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
8:35am
6-K
EX-99.1
j58x lihmm8oy1v76
20 Feb 24
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
4:27pm
6-K
EX-99.1
mm9pyj8m
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm
6-K
EX-4.1
x9zkgo4tfae
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-10.1
2ab322
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-99.1
y662n6
22 Jan 24
SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million
6:02am
6-K
EX-99.1
j4bv117adscyl4qf
8 Dec 23
SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel
8:47am
6-K
EX-99.1
kfo901hycq3ejhx3b8
28 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
EX-99.1
1ottbstcy
28 Nov 23
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment
4:00pm
6-K
EX-99.1
6207xrw0ya3l5
27 Nov 23
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
4:00pm
6-K
EX-99.1
xrqr0rlwh 0a
22 Nov 23
SciSparc Signs Non-Binding Letter of Intent to Merge with Leading Vehicle Importer Company in Israel
4:01pm
F-3/A
y535fjt9gax 09fu
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
F-3
qfn8154lv4
3 Nov 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
anq439r1
31 Oct 23
SciSparc Granted Patent from the Australian Patent Office for its Reduction of Opioids Use in Pain Management Technology
8:15am
6-K
EX-99.1
ceq vv9v7h
24 Oct 23
SciSparc Granted Patent for its Core Technology From the Australian Patent Office
7:54am
6-K
EX-99.1
92a y58p5vhu4s
18 Oct 23
Report of Foreign Private Issuer
6:54am
6-K
EX-99.2
77nsceeq5rcqc3smuh9
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
9ngilbgdz1 jw8
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am
6-K
EX-99.1
6jhzfo7vbfm 25lvijef
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am